CDC-RFA-GH-23-0016: Supporting Continuous Quality Improvement, Partnerships, and Innovation for Sustained and Responsive Laboratory Systems, Tiered Diagnostic Networks, and Laboratory Data Management under the President's Emergency Plan for AIDS Relief (PEPFAR)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - CGH notices from 2023.
Centers for Disease Control - CGH offered grants to any type of organization. It expected to make about 4 awards. Applications closed on April 7, 2023.
From the official notice on Grants.gov, last changed April 4, 2023. Checked November 7, 2026.
- Expected awards4
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | February 3, 2023 |
|---|---|
| Deadline | April 7, 2023 |
| Archived by Grants.gov | May 7, 2023 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (62% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $30,000,000 for Year 1, subject to the availability of funds. The approximate Total Fiscal Year Funding amount for Year 1 is $30,000,000. The expected number of awards is 1-4.For this NOFO, applicants should develop a proposal to spend up to $30,000,000 carrying out activities that support global and regional (e.g., Africa, Asia, and/or Western Hemisphere) PEPFAR/CDC laboratory systems strengthening priorities. It is at the applicant's discretion to select region(s) for their proposal, but applicants should propose to conduct activities that could be applied globally or adapted to other geographies in addition to activities that support the needs of the region(s) they select. Exact funding amounts and the geographic scope for each award under this NOFO will be determined at the time of award. Efficient and effective laboratory systems remain essential for the prevention, detection, and treatment of HIV, TB, and other HIV-related diseases and conditions. Historically siloed by function and funding, recent outbreaks and pandemics, coupled with advances in multi-pathogen diagnostic platforms, have highlighted the importance of accurate and responsive laboratory systems and diagnostic networks to support country needs for sustained HIV and TB control along with pandemic preparedness. This NOFO will focus on partnerships and capacity building for the timely evaluation, validation, and implementation of novel in-house and commercial diagnostics and testing algorithms; expansion of regional, national, and sub-national programs for laboratory systems capacity; and continuous quality improvement (CQI) programs and tools for point of care (POC) testing sites, laboratories, clinic-laboratory interface, and multi-disease public health diagnostic networks.
Who has won Global AIDS grants before
From fiscal 2021 to 2025, Global AIDS (93.067) awarded $7.6 billion across 521 grant awards, an average of $14.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of Columbia University in the City of New York | New York | 32 | $684 million |
| Elizabeth Glaser Pediatric AIDS Foundation | District of Columbia | 13 | $387 million |
| Management and Development for Health | 5 | $282 million | |
| Apin Public Health Initiatives LTD/Gte | 4 | $209 million | |
| University of Washington | Washington | 8 | $195 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-GH-23-0016 still open?
No. It closed on April 7, 2023.
Who can apply for Supporting Continuous Quality Improvement, Partnerships, and Innovation for Sustained and Responsive Laboratory Systems, Tiered Diagnostic Networks, and Laboratory Data Management under the President's Emergency Plan for AIDS Relief (PEPFAR)?
Centers for Disease Control - CGH accepted applications from any type of organization.
What is the deadline for Supporting Continuous Quality Improvement, Partnerships, and Innovation for Sustained and Responsive Laboratory Systems, Tiered Diagnostic Networks, and Laboratory Data Management under the President's Emergency Plan for AIDS Relief (PEPFAR)?
Closed April 7, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won Global AIDS grants before?
The largest recipients over five fiscal years were The Trustees of Columbia University in the City of New York, Elizabeth Glaser Pediatric AIDS Foundation, Management and Development for Health. The program made 521 awards worth $7.6 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)